Human anti-SOD1 antibodies
US11352441B2 · kind B2 · utility
0Cited by
4References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 28, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Aug 31, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/285
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel human copper-zinc superoxide dismutase, also known as superoxide dismutase 1 or SOD1, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for SOD1 are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for SOD1 targeted immunotherapy and diagnosis, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.